{"analyses":[{"ciLowerLimit":"0.17","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"2.14","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.4297","paramType":"Hazard Ratio (HR)","paramValue":"0.60","statisticalMethod":"Log Rank"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.75","upperLimit":"0.98","value":"0.93"},{"groupId":"OG001","lowerLimit":"0.74","upperLimit":"0.98","value":"0.93"}]}],"title":"6 months"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.59","upperLimit":"0.91","value":"0.80"},{"groupId":"OG001","lowerLimit":"0.74","upperLimit":"0.98","value":"0.93"}]}],"title":"12 months"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.54","upperLimit":"0.88","value":"0.76"},{"groupId":"OG001","lowerLimit":"0.69","upperLimit":"0.96","value":"0.89"}]}],"title":"18 months"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.54","upperLimit":"0.88","value":"0.76"},{"groupId":"OG001","lowerLimit":"0.64","upperLimit":"0.94","value":"0.85"}]}],"title":"24 months"}],"denoms":[{"counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"30"}],"units":"Participants"}],"description":"Relapse-free survival was defined as the time from transplant to relapse or death due to the disease 24 months post-transplant. If a patient had more than one event (e.g., relapse then death) then the earliest date was taken into account.","dispersionType":"95% Confidence Interval","groups":[{"description":"Patients received standard of care in the post stem cell transplant (SCT) setting in addition to Midostaurin 50mg twice a day for 12 months (cycles).","id":"OG000","title":"Standard of Care With Midostaurin"},{"description":"Patients received standard of care alone in the post SCT setting","id":"OG001","title":"Standard of Care"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"date of transplant up to 24 months","title":"Proportion of Participants With Relapse Free Survival (RFS) - Time From Transplant (Full Analysis Set) by Kaplan-Meier Analysis","type":"SECONDARY","unitOfMeasure":"Proportion of participants"}